{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:20:01Z","timestamp":1792592401530,"version":"4.5.0"},"reference-count":60,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVES:<\/jats:title>\n                  <jats:p>To determine the prevalence of alternative causes of liver disease in a cohort of youth with overweight and obesity undergoing evaluation for suspected nonalcoholic fatty liver disease (NAFLD).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS:<\/jats:title>\n                  <jats:p>Multicenter, retrospective cohort study of patients aged \u226418 years with overweight and obesity and evidence of elevated serum aminotransferases and\/or hepatic steatosis on imaging, referred for suspected NAFLD to Cincinnati Children\u2019s Hospital Medical Center (2009\u20132017) or Yale New Haven Children's Hospital (2012\u20132017). Testing was performed to exclude the following: autoimmune hepatitis (AIH), Wilson disease, viral hepatitis (B and C), thyroid dysfunction, celiac disease, \u03b1-1 antitrypsin deficiency, and hemochromatosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS:<\/jats:title>\n                  <jats:p>A total of 900 children with overweight and obesity (63% boys, 26% Hispanic ethnicity) were referred, with a median age of 13 years (range: 2\u201318). Most had severe obesity (n = 666; 76%) with a median BMI z score of 2.45 (interquartile range [IQR]: 2.2\u20132.7). Median alanine aminotransferase level at presentation was 64 U\/L (IQR: 42\u201395). A clinically indicated liver biopsy was performed in 358 children (40%) at a median of 6 months (IQR: 1\u201314) post initial visit; of those, 46% had confirmed nonalcoholic steatohepatitis. Positive autoantibodies were observed in 13% of the cohort, but none met criteria for AIH. Only 19 (2%) were found to have other causes of liver disease, with no cases of viral hepatitis or Wilson disease detected.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS:<\/jats:title>\n                  <jats:p>In a large, multicenter cohort, the vast majority of children with overweight and obesity with presumed or confirmed NAFLD tested negative for other causes of liver disease. In contrast to a previous pediatric report, no patient was diagnosed with AIH.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.2020-009829","type":"journal-article","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T08:25:14Z","timestamp":1617092714000},"source":"Crossref","is-referenced-by-count":24,"title":["Alternative Etiologies of Liver Disease in Children With Suspected NAFLD"],"prefix":"10.1542","volume":"147","author":[{"given":"Toshifumi","family":"Yodoshi","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Orkin","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Catalina","family":"Arce-Clachar","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio;"},{"name":"Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, Ohio; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Bramlage","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavra A.","family":"Xanthakos","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio;"},{"name":"Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, Ohio; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela L.","family":"Valentino","sequence":"additional","affiliation":[{"name":"Section of Gastroenterology and Hepatology, Department of Pediatrics, School of Medicine, Yale University, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialena","family":"Mouzaki","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio;"},{"name":"Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, Ohio; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"issue":"2","key":"2021121008111033100_B1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","article-title":"NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)","volume":"64","author":"Vos","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"2021121008111033100_B2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MCG.0000000000000925","article-title":"Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in young adults in the United States","volume":"52","author":"Doycheva","year":"2018","journal-title":"J Clin Gastroenterol"},{"issue":"10","key":"2021121008111033100_B3","doi-asserted-by":"crossref","first-page":"e0140908","DOI":"10.1371\/journal.pone.0140908","article-title":"The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis","volume":"10","author":"Anderson","year":"2015","journal-title":"PLoS One"},{"key":"2021121008111033100_B4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jpeds.2018.05.024","article-title":"Assessment of nonalcoholic fatty liver disease progression in children using magnetic resonance imaging","volume":"201","author":"Mouzaki","year":"2018","journal-title":"J Pediatr"},{"issue":"2","key":"2021121008111033100_B5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cld.2015.10.003","article-title":"The progression and natural history of pediatric nonalcoholic fatty liver disease","volume":"20","author":"Goyal","year":"2016","journal-title":"Clin Liver Dis"},{"issue":"11","key":"2021121008111033100_B6","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1136\/gut.2008.171280","article-title":"The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years","volume":"58","author":"Feldstein","year":"2009","journal-title":"Gut"},{"issue":"9","key":"2021121008111033100_B7","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1111\/j.1572-0241.2002.06003.x","article-title":"Obese children with steatohepatitis can develop cirrhosis in childhood","volume":"97","author":"Molleston","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"2021121008111033100_B8","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cgh.2008.03.001","article-title":"Nonalcoholic fatty liver disease in children: a single center experience","volume":"6","author":"A-Kader","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"2021121008111033100_B9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MPG.0000000000002401","article-title":"Psychotropic medications are associated with increased liver disease severity in pediatric nonalcoholic fatty liver disease","volume":"69","author":"Mouzaki","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"11","key":"2021121008111033100_B10","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1210\/jc.2006-1010","article-title":"Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat","volume":"91","author":"Burgert","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2021121008111033100_B11","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1067\/S0022-3476(03)00325-1","article-title":"Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease","volume":"143","author":"Schwimmer","year":"2003","journal-title":"J Pediatr"},{"issue":"4","key":"2021121008111033100_B12","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/hep.23133","article-title":"Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study","volume":"50","author":"Carter-Kent","year":"2009","journal-title":"Hepatology"},{"key":"2021121008111033100_B13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jpeds.2020.03.038","article-title":"Glomerular hyperfiltration is associated with liver disease severity in children with nonalcoholic fatty liver disease","volume":"222","author":"Yodoshi","year":"2020","journal-title":"J Pediatr"},{"issue":"11","key":"2021121008111033100_B14","doi-asserted-by":"crossref","first-page":"e112569","DOI":"10.1371\/journal.pone.0112569","article-title":"Longitudinal assessment of high blood pressure in children with nonalcoholic fatty liver disease","volume":"9","author":"Schwimmer","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"2021121008111033100_B15","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.2337\/dc07-1088","article-title":"Intrahepatic fat accumulation and alterations in lipoprotein composition in obese adolescents: a perfect proatherogenic state","volume":"30","author":"Cali","year":"2007","journal-title":"Diabetes Care"},{"issue":"3","key":"2021121008111033100_B16","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/MPG.0000000000000584","article-title":"Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease","volume":"60","author":"Corey","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"2021121008111033100_B17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.atherosclerosis.2009.10.014","article-title":"Intima-media thickness and liver histology in obese children and adolescents with non-alcoholic fatty liver disease","volume":"209","author":"Manco","year":"2010","journal-title":"Atherosclerosis"},{"issue":"4","key":"2021121008111033100_B18","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jpeds.2013.10.072","article-title":"Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease","volume":"164","author":"Sundaram","year":"2014","journal-title":"J Pediatr"},{"issue":"10","key":"2021121008111033100_B19","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/apt.12518","article-title":"Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease","volume":"38","author":"Schwimmer","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"2021121008111033100_B20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/pedi.12773","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: definition, epidemiology, and classification of diabetes in children and adolescents","volume":"19","author":"Mayer-Davis","year":"2018","journal-title":"Pediatr Diabetes"},{"issue":"3","key":"2021121008111033100_B21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1148\/radiol.2020201513","article-title":"Normal liver stiffness measured with MR elastography in children","volume":"297","author":"Trout","year":"2020","journal-title":"Radiology"},{"issue":"4","key":"2021121008111033100_B22","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1053\/j.gastro.2009.12.052","article-title":"SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease","volume":"138","author":"Schwimmer","year":"2010","journal-title":"Gastroenterology"},{"key":"2021121008111033100_B23","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1542\/peds.2007-2329D","article-title":"Assessment of child and adolescent overweight and obesity","volume":"120","author":"Krebs","year":"2007","journal-title":"Pediatrics"},{"issue":"7","key":"2021121008111033100_B24","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1002\/jpen.1766","article-title":"Identifying predictors of response to vitamin E for the treatment of pediatric nonalcoholic steatohepatitis","volume":"44","author":"Yodoshi","year":"2020","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"2","key":"2021121008111033100_B25","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"issue":"6","key":"2021121008111033100_B26","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1002\/hep.22261","article-title":"Diagnosis and treatment of Wilson disease: an update","volume":"47","author":"Roberts","year":"2008","journal-title":"Hepatology"},{"issue":"12","key":"2021121008111033100_B27","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1089\/thy.2012.0205","article-title":"Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. [published corrections appear in Thyroid. 2013;23(2):251 and Thyroid. 2013;23(1):129]","volume":"22","author":"Garber","year":"2012","journal-title":"Thyroid"},{"issue":"6","key":"2021121008111033100_B28","first-page":"593","article-title":"Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. [published corrections appears in Thyroid. 2011;21(10):1169 and Thyroid. 2012;22(11):1195]","volume":"21","author":"Bahn Chair","year":"2011","journal-title":"Thyroid"},{"issue":"1","key":"2021121008111033100_B29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MPG.0000000000001216","article-title":"NASPGHAN clinical report on the diagnosis and treatment of gluten-related disorders","volume":"63","author":"Hill","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2021121008111033100_B30","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1097\/01.mpg.0000226387.56612.1e","article-title":"Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study","volume":"43","author":"Regev","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"2021121008111033100_B31","first-page":"8","article-title":"Alpha-1-antitrypsin deficiency: an important cause of pediatric liver disease","volume":"4","author":"Feldman","year":"2013","journal-title":"Lung Health Prof Mag"},{"issue":"1","key":"2021121008111033100_B32","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.24330","article-title":"Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases","volume":"54","author":"Bacon","year":"2011","journal-title":"Hepatology"},{"issue":"6","key":"2021121008111033100_B33","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"8","key":"2021121008111033100_B34","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.metabol.2015.11.008","article-title":"Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"65","author":"Brown","year":"2016","journal-title":"Metabolism"},{"issue":"2","key":"2021121008111033100_B35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","article-title":"Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN hepatology committee position statement","volume":"66","author":"Mieli-Vergani","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"2021121008111033100_B36","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bpg.2010.07.014","article-title":"Wilson disease","volume":"24","author":"Huster","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"1","key":"2021121008111033100_B37","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2015.01.034","article-title":"Hepatic steatosis in Wilson disease\u2013Role of copper and PNPLA3 mutations","volume":"63","author":"St\u00e4ttermayer","year":"2015","journal-title":"J Hepatol"},{"issue":"5","key":"2021121008111033100_B38","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/archdischild-2018-315705","article-title":"Wilson disease in children and adolescents","volume":"105","author":"Fernando","year":"2020","journal-title":"Arch Dis Child"},{"issue":"3","key":"2021121008111033100_B39","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41430-019-0493-y","article-title":"Vitamin D deficiency: prevalence and association with liver disease severity in pediatric nonalcoholic fatty liver disease","volume":"74","author":"Yodoshi","year":"2020","journal-title":"Eur J Clin Nutr"},{"issue":"42","key":"2021121008111033100_B40","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.3748\/wjg.v18.i42.6036","article-title":"Celiac disease: prevalence, diagnosis, pathogenesis and treatment","volume":"18","author":"Gujral","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"6","key":"2021121008111033100_B41","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.jhep.2015.01.013","article-title":"Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease","volume":"62","author":"Reilly","year":"2015","journal-title":"J Hepatol"},{"issue":"19\u201320","key":"2021121008111033100_B42","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.cca.2012.05.015","article-title":"IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases","volume":"413","author":"Gatselis","year":"2012","journal-title":"Clin Chim Acta"},{"issue":"11","key":"2021121008111033100_B43","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1111\/j.1572-0241.2005.00244.x","article-title":"Anti-tissue transglutaminase antibodies in patients with abnormal liver tests: is it always coeliac disease?","volume":"100","author":"Lo Iacono","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"2021121008111033100_B44","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4318\/tjg.2011.0216","article-title":"The prevalence of celiac disease among patients with non-alcoholic fatty liver disease in Iran","volume":"22","author":"Rahimi","year":"2011","journal-title":"Turk J Gastroenterol"},{"issue":"12","key":"2021121008111033100_B45","doi-asserted-by":"crossref","first-page":"e557","DOI":"10.1111\/apa.13176","article-title":"Yield of diagnostic tests in obese children with an elevated alanine aminotransferase","volume":"104","author":"Rudolph","year":"2015","journal-title":"Acta Paediatr"},{"key":"2021121008111033100_B46","doi-asserted-by":"crossref","first-page":"i941","DOI":"10.1136\/bmj.i941","article-title":"Should we treat subclinical hypothyroidism in obese children?","volume":"352","author":"Niranjan","year":"2016","journal-title":"BMJ"},{"issue":"4","key":"2021121008111033100_B47","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/MOP.0b013e328344c393","article-title":"Thyroid function in the nutritionally obese child and adolescent","volume":"23","author":"Reinehr","year":"2011","journal-title":"Curr Opin Pediatr"},{"issue":"1","key":"2021121008111033100_B48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/EJE-19-0666","article-title":"Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis","volume":"182","author":"van Hulsteijn","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2021121008111033100_B49","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.dld.2018.12.014","article-title":"Pathogenesis of hypothyroidism-induced NAFLD: evidence for a distinct disease entity?","volume":"51","author":"Lonardo","year":"2019","journal-title":"Dig Liver Dis"},{"key":"2021121008111033100_B50","doi-asserted-by":"crossref","first-page":"381014","DOI":"10.1155\/2013\/381014","article-title":"Hepatic steatosis and thyroid function tests in overweight and obese children","volume":"2013","author":"Pacifico","year":"2013","journal-title":"Int J Endocrinol"},{"issue":"1","key":"2021121008111033100_B51","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/ijpo.12110","article-title":"Thyroid dysfunction and hepatic steatosis in overweight children and adolescents","volume":"12","author":"Kaltenbach","year":"2017","journal-title":"Pediatr Obes"},{"key":"2021121008111033100_B52","doi-asserted-by":"crossref","first-page":"5753039","DOI":"10.1155\/2017\/5753039","article-title":"Benefits of levothyroxine replacement therapy on nonalcoholic fatty liver disease in subclinical hypothyroidism patients","volume":"2017","author":"Liu","year":"2017","journal-title":"Int J Endocrinol"},{"issue":"7","key":"2021121008111033100_B53","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1210\/jc.2018-00475","article-title":"Low-dose levothyroxine reduces intrahepatic lipid content in patients with type 2 diabetes mellitus and NAFLD","volume":"103","author":"Bruinstroop","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2021121008111033100_B54","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(18)30292-7","article-title":"MGL-3196, a selective thyroid hormone receptor-beta agonist, significantly decreases hepatic fat in NASH patients at 12 weeks, the primary endpoint in a 36 week serial liver biopsy study","volume":"68","author":"Harrison","year":"2018","journal-title":"J Hepatol"},{"issue":"5","key":"2021121008111033100_B55","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/archpedi.160.5.531","article-title":"Genetic testing of minors for alpha1-antitrypsin deficiency","volume":"160","author":"Strange","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"6","key":"2021121008111033100_B56","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/gutjnl-2018-316228","article-title":"Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis","volume":"68","author":"Strnad","year":"2019","journal-title":"Gut"},{"issue":"15","key":"2021121008111033100_B57","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMra1910234","article-title":"Alpha1-antitrypsin deficiency","volume":"382","author":"Strnad","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"2021121008111033100_B58","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/MEG.0000000000001056","article-title":"Both \u03b1-1-antitrypsin Z phenotypes and low caeruloplasmin levels are over-represented in alcohol and nonalcoholic fatty liver disease cirrhotic patients undergoing liver transplant in Ireland","volume":"30","author":"El-Rayah","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"10","key":"2021121008111033100_B59","doi-asserted-by":"crossref","first-page":"e161971","DOI":"10.1001\/jamapediatrics.2016.1971","article-title":"Prevalence of prediabetes and type 2 diabetes in children with nonalcoholic fatty liver disease","volume":"170","author":"Newton","year":"2016","journal-title":"JAMA Pediatr"},{"issue":"4","key":"2021121008111033100_B60","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jpeds.2013.10.071","article-title":"Histological abnormalities in children with nonalcoholic fatty liver disease and normal or mildly elevated alanine aminotransferase levels","volume":"164","author":"Molleston","year":"2014","journal-title":"J Pediatr"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2020-009829\/1181851\/peds_2020009829.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2020-009829\/1181851\/peds_2020009829.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T20:03:56Z","timestamp":1639166636000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/147\/4\/e2020009829\/180818\/Alternative-Etiologies-of-Liver-Disease-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":60,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,1]]},"published-print":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2020-009829","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"article-number":"e2020009829"}}